As the race for the coronavirus vaccine continues, many of the vaccine applicants for the test are reaching the last level of human trials. The effects of these tests will determine whether they will have the green light to manufacture and distribute the vaccine in countries around the world.
When a vaccine was approved, many evolved countries spent billions of dollars getting doses of candidate vaccines. However, the World Health Organization (WHO) warns that the monopolization of vaccines may not help curb the ongoing pandemic, especially if poorer countries are still exposed to threats of coronavirus disease (COVID-19), the condition caused by severe acute respiratory syndrome. . coronavirus 2 (SARS-CoV-2).
WHO has reported clinical evaluation or testing 26 human candidate vaccines. Of these, six experimental vaccines are now in the last phase or level of clinical trials. These come with vaccines developed through Oxford University/AstraZeneca, Sinovac, Wuhan/Sinopharm Institute of Biological Products, Beijing/Sinopharm Institute of Biological Products, Modern/NIAID and BioNTech/Fosun Pharma/Pfizer. Meanwhile, 139 candidate vaccines are under preclinical evaluation.
WHO has stated that potential vaccines that oppose coronaviruses entering the final phase of human trials do not necessarily mean that they are almost in a position to be widely distributed to the general public.
“Phase 3 doesn’t mean almost there. Phase 3 means this is the first time this vaccine has been taken to the general population in a different way than healthy Americans to see if the vaccine will protect them from herbal infections,” Mike Ryan, Executive Director of WHO’s Health Emergencies Program, at a press conference.
So far, trials have been aimed at determining whether vaccines should be used and can cause an immune response.
Vaccine nationalism, where countries that produce a vaccine that opposes coronavirus will not share it with others, can create disruptions for countries that expand their own.
WHO has warned that it opposes vaccine nationalism, warning that more rich countries can disgustingly keep the remedies for themselves, which will not guarantee that they are if poor countries remain threatened and exposed to the virus.
“Sharing vaccines or sharing other teams is helping the world get back together. Economic recovery may be faster and the damage caused by COVID-19 may be less.” Vaccine nationalism is not good, it won’t help us,” dr. Tedros Adhanom Ghebreyesus said in a statement.
“For the global to be faster, it will have to rejoin, because it is a globalization: economies are intertwined. A component of the global or some countries cannot be a safe haven and Array,” he added.
Dr. Tedros also noted that the damage caused by the pandemic could be less if countries that can vaccines are dedicated to joining other nations of the world. He also said it was helping at-risk countries, especially poor countries that cannot supply enough vaccines to the masses.
As global bodies rise to 19.79 million other people worldwide, countries desperately want an effective vaccine to protect their populations from infection. At the time of writing, the death toll exceeded 731,000, with the highest number of deaths reported in the United States. The country has recorded more than five million cases since it reported its first case in March.
South America and North America have the epicenter of the coronavirus pandemic, with Brazil, Peru, Colombia and Chile reporting the highest number of cases. In addition to the United States, Brazil reports more than 3 million cases.
Other countries with the highest number of instances are India with more than 2.21 million instances shown, Russia with more than 885,000 instances, South Africa with more than 559,000 instances and Mexico with more than 480,000 instances. Peru, Colombia and Chile followed with more than 478,000, 387,000 and 373,000 instances, respectively.
In Southeast Asia, the Philippines reported the number of instances, with more than 129,000 instances, followed across Indonesia, with an impressive 125,000 instances. At the other end of the spectrum, New Zealand announces its good luck in combating the risk of SARS-CoV-2 by reporting a hundred days without the spread of the COVID-19 community. The country has 1,569 instances and 22 deaths to date.
Written by
Angela is a career and heart nurse. He graduated by far (Cum Laude) from his Bachelor of Nursing from Baguio University, Philippines. Lately she is completing her master’s degree where she specialized in maternal and child nursing and has served as a clinical instructor and educator at the School of Nursing at the University of Baguio.
Use one of the following to cite this article in your essay, job, or report:
Apa
Laguipus, Angela. (2020, 10 August). Vaccine ‘nationalism’ will slow down the fight against coronaviruses if poor countries are exposed. News-Medical. Retrieved 25 August 2020 in https://www.news-medical.net/news/20200810/Vaccine-nationalism-will-slow-coronavirus-combat-if-defficient-countries-are-left-exposed.aspx.
Mla
Laguipus, Angela. “Vaccine nationalism will curb the fight against coronaviruses if poor countries are exposed.” News-Medical. August 25, 2020.
Chicago
Laguipus, Angela. “Vaccine nationalism” will curb the fight against coronaviruses if poor countries are exposed.” News-Medical. Https://www.news-medical.net/news/20200810/Vaccine-nationalism-will-slow-coronavirus- combat-if-defficient-countries-are-left-protected.aspx. (accessed 25 August 2020).
Harvard
Laguipus, Angela. 2020. Vaccine “nationalism” will curb the fight against coronaviruses if poor countries are exposed. News-Medical, viewed 07 August 2020, https://www.news-medical.net/news/20200810/Vaccine-nationalism-will-slow-coronavirus-combat-if-defficient-countries-are-left-exposed.aspxArray
News-Medical.net – An AZoNetwork site
Ownership and operation through AZoNetwork, © 2000-2020